Medtronic Research Development vs Income Before Tax Analysis

MDT Stock

USD 84.74 0.63 0.75%

Medtronic PLC financial indicator trend analysis is infinitely more than just investigating Medtronic PLC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medtronic PLC is a good investment. Please check the relationship between Medtronic PLC Research Development and its Income Before Tax accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.

Research Development vs Income Before Tax

Research Development vs Income Before Tax Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medtronic PLC Research Development account and Income Before Tax. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Medtronic PLC's Research Development and Income Before Tax is 0.87. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Income Before Tax in the same time period over historical financial statements of Medtronic PLC, assuming nothing else is changed. The correlation between historical values of Medtronic PLC's Research Development and Income Before Tax is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Medtronic PLC are associated (or correlated) with its Income Before Tax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Before Tax has no effect on the direction of Research Development i.e., Medtronic PLC's Research Development and Income Before Tax go up and down completely randomly.

Correlation Coefficient

0.87

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Research Development

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Medtronic PLC income statement and is an important metric when analyzing Medtronic PLC profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Most indicators from Medtronic PLC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medtronic PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.At this time, Medtronic PLC's Issuance Of Capital Stock is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 24.28 in 2024, whereas Selling General Administrative is likely to drop slightly above 7.7 B in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	21.5B	20.5B	19.5B	9.8B
Total Revenue	31.7B	31.2B	32.4B	34.0B

Gross Profit Total Revenue

Medtronic PLC fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Other Liab	Other Assets	Long Term Debt
Total Assets		0.98	0.66	0.86	0.99	0.85	0.97	0.77	0.74	0.99	0.5	0.55	0.89	0.86	0.96	0.86	0.79	0.73	0.99	0.88	0.27	0.86	0.87	0.87	0.2	0.92
Short Long Term Debt Total	0.98		0.54	0.82	0.94	0.78	0.99	0.82	0.77	0.96	0.53	0.64	0.87	0.78	0.98	0.75	0.68	0.63	1.0	0.89	0.36	0.89	0.77	0.92	0.3	0.94
Other Current Liab	0.66	0.54		0.46	0.72	0.76	0.55	0.55	0.31	0.65	0.04	0.25	0.7	0.57	0.58	0.78	0.73	0.49	0.58	0.6	-0.33	0.42	0.75	0.35	-0.4	0.56
Total Current Liabilities	0.86	0.82	0.46		0.86	0.8	0.81	0.46	0.67	0.85	0.71	0.39	0.76	0.79	0.73	0.81	0.85	0.69	0.83	0.74	0.61	0.62	0.81	0.69	0.29	0.67
Total Stockholder Equity	0.99	0.94	0.72	0.86		0.89	0.94	0.73	0.7	0.99	0.49	0.49	0.88	0.89	0.93	0.9	0.85	0.77	0.96	0.85	0.22	0.82	0.92	0.81	0.14	0.89
Property Plant And Equipment Net	0.85	0.78	0.76	0.8	0.89		0.82	0.61	0.35	0.86	0.65	0.22	0.84	0.75	0.74	0.97	0.92	0.69	0.8	0.72	0.06	0.49	0.95	0.57	-0.17	0.66
Net Debt	0.97	0.99	0.55	0.81	0.94	0.82		0.83	0.69	0.95	0.57	0.59	0.89	0.77	0.98	0.79	0.7	0.63	0.99	0.88	0.3	0.85	0.8	0.9	0.23	0.92
Retained Earnings	0.77	0.82	0.55	0.46	0.73	0.61	0.83		0.5	0.73	0.16	0.65	0.77	0.51	0.86	0.56	0.37	0.32	0.81	0.79	0.04	0.75	0.55	0.75	-0.01	0.83
Cash	0.74	0.77	0.31	0.67	0.7	0.35	0.69	0.5		0.72	0.18	0.68	0.55	0.62	0.75	0.38	0.41	0.47	0.77	0.7	0.54	0.86	0.43	0.75	0.58	0.77
Non Current Assets Total	0.99	0.96	0.65	0.85	0.99	0.86	0.95	0.73	0.72		0.51	0.46	0.85	0.89	0.95	0.86	0.81	0.77	0.97	0.81	0.26	0.86	0.89	0.86	0.21	0.9
Non Currrent Assets Other	0.5	0.53	0.04	0.71	0.49	0.65	0.57	0.16	0.18	0.51		0.07	0.45	0.43	0.41	0.58	0.58	0.44	0.5	0.41	0.47	0.2	0.57	0.4	0.22	0.3
Cash And Short Term Investments	0.55	0.64	0.25	0.39	0.49	0.22	0.59	0.65	0.68	0.46	0.07		0.58	0.3	0.65	0.2	0.08	0.1	0.62	0.83	0.29	0.66	0.22	0.66	0.31	0.7
Net Receivables	0.89	0.87	0.7	0.76	0.88	0.84	0.89	0.77	0.55	0.85	0.45	0.58		0.74	0.86	0.81	0.75	0.59	0.88	0.91	0.16	0.67	0.79	0.73	-0.01	0.81
Common Stock Shares Outstanding	0.86	0.78	0.57	0.79	0.89	0.75	0.77	0.51	0.62	0.89	0.43	0.3	0.74		0.77	0.79	0.79	0.95	0.82	0.63	0.26	0.75	0.82	0.75	0.26	0.77
Non Current Liabilities Total	0.96	0.98	0.58	0.73	0.93	0.74	0.98	0.86	0.75	0.95	0.41	0.65	0.86	0.77		0.73	0.62	0.62	0.99	0.88	0.22	0.92	0.75	0.92	0.25	0.96
Inventory	0.86	0.75	0.78	0.81	0.9	0.97	0.79	0.56	0.38	0.86	0.58	0.2	0.81	0.79	0.73		0.95	0.72	0.78	0.69	0.05	0.5	0.99	0.55	-0.17	0.67
Other Current Assets	0.79	0.68	0.73	0.85	0.85	0.92	0.7	0.37	0.41	0.81	0.58	0.08	0.75	0.79	0.62	0.95		0.73	0.71	0.59	0.18	0.45	0.93	0.49	-0.06	0.56
Other Stockholder Equity	0.73	0.63	0.49	0.69	0.77	0.69	0.63	0.32	0.47	0.77	0.44	0.1	0.59	0.95	0.62	0.72	0.73		0.67	0.46	0.18	0.59	0.77	0.58	0.26	0.59
Total Liab	0.99	1.0	0.58	0.83	0.96	0.8	0.99	0.81	0.77	0.97	0.5	0.62	0.88	0.82	0.99	0.78	0.71	0.67		0.89	0.33	0.89	0.8	0.91	0.27	0.94
Total Current Assets	0.88	0.89	0.6	0.74	0.85	0.72	0.88	0.79	0.7	0.81	0.41	0.83	0.91	0.63	0.88	0.69	0.59	0.46	0.89		0.27	0.74	0.69	0.77	0.14	0.85
Short Term Debt	0.27	0.36	-0.33	0.61	0.22	0.06	0.3	0.04	0.54	0.26	0.47	0.29	0.16	0.26	0.22	0.05	0.18	0.18	0.33	0.27		0.31	0.06	0.4	0.68	0.2
Intangible Assets	0.86	0.89	0.42	0.62	0.82	0.49	0.85	0.75	0.86	0.86	0.2	0.66	0.67	0.75	0.92	0.5	0.45	0.59	0.89	0.74	0.31		0.56	0.95	0.47	0.95
Accounts Payable	0.87	0.77	0.75	0.81	0.92	0.95	0.8	0.55	0.43	0.89	0.57	0.22	0.79	0.82	0.75	0.99	0.93	0.77	0.8	0.69	0.06	0.56		0.59	-0.11	0.7
Other Liab	0.87	0.92	0.35	0.69	0.81	0.57	0.9	0.75	0.75	0.86	0.4	0.66	0.73	0.75	0.92	0.55	0.49	0.58	0.91	0.77	0.4	0.95	0.59		0.48	0.94
Other Assets	0.2	0.3	-0.4	0.29	0.14	-0.17	0.23	-0.01	0.58	0.21	0.22	0.31	-0.01	0.26	0.25	-0.17	-0.06	0.26	0.27	0.14	0.68	0.47	-0.11	0.48		0.25
Long Term Debt	0.92	0.94	0.56	0.67	0.89	0.66	0.92	0.83	0.77	0.9	0.3	0.7	0.81	0.77	0.96	0.67	0.56	0.59	0.94	0.85	0.2	0.95	0.7	0.94	0.25

Click cells to compare fundamentals

Medtronic PLC Account Relationship Matchups

Medtronic PLC fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	90.7B	93.1B	91.0B	90.9B	90.0B	94.5B
Short Long Term Debt Total	24.8B	26.4B	24.1B	24.4B	26.0B	27.3B
Other Current Liab	5.6B	5.8B	5.7B	5.3B	5.8B	6.1B
Total Current Liabilities	10.4B	8.5B	12.4B	9.1B	10.8B	11.3B
Total Stockholder Equity	50.7B	51.4B	52.6B	51.5B	50.2B	52.7B
Property Plant And Equipment Net	4.8B	5.2B	5.4B	5.6B	7.1B	7.5B
Net Debt	20.7B	22.8B	20.4B	22.8B	24.8B	26.0B
Retained Earnings	28.1B	28.6B	30.3B	30.4B	30.4B	31.9B
Cash	4.1B	3.6B	3.7B	1.5B	1.3B	1.6B
Non Current Assets Total	68.7B	70.5B	67.9B	69.3B	68.0B	71.4B
Non Currrent Assets Other	1.6B	1.7B	2.0B	2.3B	5.1B	5.3B
Cash And Short Term Investments	10.9B	10.8B	10.6B	8.0B	8.0B	4.9B
Net Receivables	4.6B	5.5B	5.6B	6.0B	6.1B	6.4B
Common Stock Shares Outstanding	1.4B	1.4B	1.4B	1.3B	1.3B	1.2B
Liabilities And Stockholders Equity	90.7B	93.1B	91.0B	90.9B	90.0B	94.5B
Non Current Liabilities Total	29.5B	33.0B	25.9B	30.2B	28.8B	30.2B
Inventory	4.2B	4.3B	4.6B	5.3B	5.2B	5.5B
Other Current Assets	2.2B	2.0B	2.3B	2.4B	2.6B	2.7B
Other Stockholder Equity	26.2B	26.3B	24.6B	24.6B	23.1B	24.3B
Total Liab	39.8B	41.5B	38.3B	39.3B	39.6B	41.5B
Total Current Assets	22.0B	22.5B	23.1B	21.7B	21.9B	23.0B
Short Term Debt	2.8B	197M	3.7B	200M	1.3B	1.2B
Intangible Assets	19.1B	17.7B	15.6B	14.8B	13.2B	6.9B
Accounts Payable	2.0B	2.1B	2.3B	2.7B	2.4B	2.5B
Other Liab	6.7B	5.8B	5.5B	6.8B	7.8B	3.9B
Other Assets	2.1B	3.5B	1M	(1M)	(1.2M)	(1.1M)
Long Term Debt	22.0B	26.4B	20.4B	24.3B	23.9B	14.3B
Good Will	39.8B	42.0B	40.5B	41.4B	41.0B	21.9B
Short Term Investments	6.8B	7.2B	6.9B	6.4B	6.7B	5.1B
Accumulated Other Comprehensive Income	(3.6B)	(3.5B)	(2.3B)	(3.5B)	(3.3B)	(3.2B)
Common Stock	134.1K	134.5K	133.1K	133.1K	119.8K	113.8K
Property Plant Equipment	4.8B	6.2B	5.4B	6.6B	7.6B	8.0B
Property Plant And Equipment Gross	5.8B	5.2B	13.4B	14.1B	14.1B	14.8B
Short Long Term Debt	2.8B	11M	3.7B	20M	1.1B	1.0B
Net Tangible Assets	50.7B	(8.3B)	(3.5B)	51.5B	59.2B	62.2B
Deferred Long Term Liab	1.2B	1.0B	884M	708M	637.2M	605.3M
Noncontrolling Interest In Consolidated Entity	135M	174M	171M	182M	209.3M	123.1M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Medtronic Stock Analysis

When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC